Most Read This Week
- ASCO Guidelines on Cannabis and Cannabinoid Use in Adults With Cancer
- FDA Approves New Antibiotic for Three Indications
- Pembrolizumab With Chemoradiotherapy Followed by Pembrolizumab for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer
- Outcomes of Fulvestrant, Palbociclib, and Avelumab Treatment After Progression on CDK4/6i and Aromatase Inhibitor Therapy for HR+/HER2− Metastatic Breast Cancer
- Association of Progestogen Use With the Risk of Intracranial Meningioma
Recently Updated
- Preoperative Durvalumab or Durvalumab Plus Tremelimumab for Resectable HNSCC
- Association Between Chronic Stress and Metastasis in Patients With Cancer
- Outcomes of Tucatinib Combination Treatment After Trastuzumab Deruxtecan Therapy in Patients With ERBB2-Positive Metastatic Breast Cancer
- AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
- Adjuvant Alectinib Improves Disease-Free Survival in Lung Cancer